Use of wearable cardioverter-defibrillator in association with catheter ablation for atrial fibrillation-related tachycardiomyopathy

Sergio Conti; Vito Bonomo; Antonio Taormina; Umberto Giordano; Giuseppe Sgarito

doi:10.1002/ccr3.2089

Use of wearable cardioverter-defibrillator in association with catheter ablation for atrial fibrillation-related tachycardiomyopathy

Clin Case Rep. 2019 Apr 10;7(5):995-998. doi: 10.1002/ccr3.2089. eCollection 2019 May.

Authors

Sergio Conti^{1

2}, Vito Bonomo^{1

3}, Antonio Taormina^{1

4}, Umberto Giordano¹, Giuseppe Sgarito¹

Affiliations

¹ ARNAS Ospedale Civico - Di Cristina - Benfratelli Palermo Italy.
² University of Tor Vergata Rome Italy.
³ University of Palermo Palermo Italy.
⁴ University of Messina Messina Italy.

Abstract

Implantable cardioverter-defibrillator (ICD) is an effective therapy in patients known to be at high risk for sudden cardiac death (SCD). Nevertheless, ICD implantation is not indicated in transient or reversible causes of SCD. Wearable cardioverter-defibrillator is increasingly used for SCD prevention in patients with a transient risk of ventricular arrhythmia.

Keywords: atrial fibrillation; catheter ablation; implantable cardioverter defibrillator; wearable cardioverter defibrillator.

Publication types

Case Reports